{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:03:23Z","timestamp":1780920203187,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010253","name":"UBACyT","doi-asserted-by":"crossref","award":["20020100100246"],"award-info":[{"award-number":["20020100100246"]}],"id":[{"id":"10.13039\/501100010253","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Veterinary Science"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.rvsc.2014.07.014","type":"journal-article","created":{"date-parts":[[2014,7,29]],"date-time":"2014-07-29T23:30:57Z","timestamp":1406676657000},"page":"211-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Involvement of glucagon-like peptide 1 in the glucose homeostasis regulation in obese and pituitary-dependent hyperadrenocorticism affected dogs"],"prefix":"10.1016","volume":"97","author":[{"given":"D.D.","family":"Miceli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Cabrera Blatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.F.","family":"Gallelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.P.","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.A.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rvsc.2014.07.014_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EC-12-0079","article-title":"Upregulated insulin secretion in insulin-resistant mice: evidence of increased islet GLP1 receptor levels and GPR119-activated GLP1 secretion","volume":"18","author":"Ahlkvist","year":"2013","journal-title":"Endocrine Connections"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/cs0960513","article-title":"Glucocorticoids and insulin resistance. Old hormones, new targets","volume":"96","author":"Andrews","year":"1999","journal-title":"Clinical Science (London)"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0020","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0025","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.2337\/diacare.17.11.1269","article-title":"The ROC curve in the evaluation of fasting capillary blood glucose as a screening test for diabetes and IGT","volume":"17","author":"Borthery","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0030","first-page":"S29","article-title":"Management of obesity \u2013 the clinical nutritionist's experience","volume":"18","author":"Buffington","year":"1994","journal-title":"International Journal of Obesity and Related Metabolic Disorders"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0035","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.rvsc.2012.02.003","article-title":"Interleukin-6 and insulin increase and nitric oxide and adiponectin decrease in blind dogs with pituitary-dependent hyperadrenocorticism","volume":"93","author":"Cabrera Blatter","year":"2012","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0034-5288(18)32641-9","article-title":"A comparison of intravenous and oral glucose tolerance tests in the dog","volume":"29","author":"Church","year":"1980","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0045","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.regpep.2004.06.007","article-title":"What do we know about the secretion and degradation of incretin hormones?","volume":"128","author":"Deacon","year":"2005","journal-title":"Regulatory Peptides"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0050","doi-asserted-by":"crossref","first-page":"525093","DOI":"10.1155\/2012\/525093","article-title":"Glucocorticoids and type 2 diabetes: from physiology to pathology","volume":"2012","author":"Di Dalmazi","year":"2012","journal-title":"Journal of Nutrition and Metabolism"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0195-5616(84)50084-9","article-title":"Diabetes mellitus associated with other endocrine disorders","volume":"14","author":"Eigenmann","year":"1984","journal-title":"The Veterinary Clinics of North America. Small Animal Practice"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/01652176.1997.9694731","article-title":"Urinary corticoid\/creatinine ratios in the differentiation between pituitary-dependent hyperadrenocorticism and hyperadrenocorticism due to adrenocortical tumour in the dog","volume":"19","author":"Galac","year":"1997","journal-title":"The Veterinary Quarterly"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rvsc.2009.06.011","article-title":"A comparative study by age and gender of the pituitary adenoma and ACTH and a-MSH secretion in dogs with pituitary-dependent hyperadrenocorticism","volume":"88","author":"Gallelli","year":"2010","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0070","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.2460\/javma.2000.217.1166","article-title":"Concurrent disorders in dogs with diabetes mellitus: 221 cases (1993\u20131998)","volume":"217","author":"Hess","year":"2000","journal-title":"Journal American Veterinary Medical Association"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0303-7207(02)00264-2","article-title":"Comparative aspects of diabetes mellitus in dogs and cats","volume":"197","author":"Hoenig","year":"2002","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.domaniend.2009.08.004","article-title":"Oral glucose leads to a differential response in glucose, insulin, and GLP-1 in lean versus obese cats","volume":"38","author":"Hoenig","year":"2010","journal-title":"Domestic Animal Endocrinology"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0085","doi-asserted-by":"crossref","first-page":"1706S","DOI":"10.1093\/jn\/132.6.1706S","article-title":"Determination of insulin sensitivity in the dog: an assessment of three methods","volume":"132","author":"Irvine","year":"2002","journal-title":"The Journal of Nutrition"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0090","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00125-012-2459-7","article-title":"Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes","volume":"55","author":"Jensen","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0095","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/edrv.20.6.0385","article-title":"The glucagon like peptides","volume":"20","author":"Kieffer","year":"1999","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.tcam.2012.06.001","article-title":"Recent advances in the diagnosis of Cushing's Syndrome in dogs","volume":"27","author":"Kooistra","year":"2012","journal-title":"Topics in Companion Animal Medicine"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0105","first-page":"10","article-title":"Development and validation of a body condition score system for dogs","volume":"22","author":"Laflamme","year":"1997","journal-title":"Canine Practice"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0110","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/dom.12119","article-title":"The role of glucagon-like peptide-1 impairment in obesity and potential therapeutic implications","volume":"16","author":"Madsbad","year":"2013","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0120","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/dmrr.538","article-title":"Glucagon-like peptide 1 (GLP-1) in biology and pathology","volume":"21","author":"Meier","year":"2005","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.rvsc.2011.07.003","article-title":"Low dose of insulin detemir controls glycaemia, insulinemia and prevents diabetes mellitus progression in the dog with pituitary-dependent hyperadrenocorticism","volume":"93","author":"Miceli","year":"2012","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2460\/javma.1981.178.01.66","article-title":"Diagnosis and management of concurrent diabetes mellitus and hyperadrenocorticism in thirty dogs","volume":"178","author":"Peterson","year":"1981","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0034-5288(18)31975-1","article-title":"Released insulin sensitivity and glucose tolerance in spontaneous canine hyperadrenocorticism","volume":"36","author":"Peterson","year":"1984","journal-title":"Research in Veterinary Science"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000314319","article-title":"Pathophysiology of diabetes mellitus in Cushing's syndrome","volume":"92","author":"Pivonello","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0150","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/gut.38.6.916","article-title":"Attenuated GLP-1 secretion in obesity: cause or consequence?","volume":"38","author":"Ranganath","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0155","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.2337\/db05-1220","article-title":"Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4","volume":"55","author":"Ranta","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0160","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.2337\/diabetes.48.5.1045","article-title":"Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs","volume":"48","author":"Sandhu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Schacke","year":"2002","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/diacare.23.1.34","article-title":"Impaired fasting glucose: how low should it go?","volume":"23","author":"Shaw","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0175","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/S0140-6736(05)61032-X","article-title":"Type 2 diabetes: principles of pathogenesis and therapy","volume":"365","author":"Stumvoll","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"378","author":"Tahrani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0185","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1210\/jcem.86.8.7750","article-title":"Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients","volume":"86","author":"Toft-Nielsen","year":"2001","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0190","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2362.2008.02067.x","article-title":"Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?","volume":"39","author":"Van Raalte","year":"2009","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mce.2007.05.015","article-title":"Glucocorticoids, metabolism and metabolic diseases","volume":"275","author":"Vegiopoulos","year":"2007","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0200","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.domaniend.2010.06.001","article-title":"Basal measures of insulin sensitivity and insulin secretion and simplified glucose tolerance tests in dogs","volume":"39","author":"Verkest","year":"2010","journal-title":"Domestic Animal Endocrinology"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0205","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.domaniend.2011.02.001","article-title":"Compensation for obesity-induced insulin resistance in dogs: assessment of the effects of leptin, adiponectin, and glucagon-like peptide-1 using path analysis","volume":"41","author":"Verkest","year":"2011","journal-title":"Domestic Animal Endocrinology"},{"key":"10.1016\/j.rvsc.2014.07.014_bib0210","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.domaniend.2011.10.002","article-title":"Spontaneously obese dogs exhibit greater postprandial glucose, triglyceride, and insulin concentrations than lean dogs","volume":"42","author":"Verkest","year":"2012","journal-title":"Domestic Animal Endocrinology"}],"container-title":["Research in Veterinary Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528814002161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0034528814002161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T04:01:23Z","timestamp":1758513683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0034528814002161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0034528814002161"],"URL":"https:\/\/doi.org\/10.1016\/j.rvsc.2014.07.014","relation":{},"ISSN":["0034-5288"],"issn-type":[{"value":"0034-5288","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of glucagon-like peptide 1 in the glucose homeostasis regulation in obese and pituitary-dependent hyperadrenocorticism affected dogs","name":"articletitle","label":"Article Title"},{"value":"Research in Veterinary Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rvsc.2014.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}